BridgeBio Pharma, Inc.'s Attruby (Acoramidis) delivers early, durable reductions in cumulative cardiovascular events. Learn ...
Envista Logo (PRNewsfoto/Envista Holdings Corporation) "This was another strong quarter for Envista, with core growth, adjusted EBITDA, and adjusted EPS all ahead of expectations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback